Aurinia Pharmaceuticals Inc - Common Shares (AUPH) stock analysis
AUPH · Aurinia Pharmaceuticals Inc - Common Shares
Latest recorded price: USD 15.48
Sector and industry: Healthcare · Biotechnology
A reliable intrinsic value could not be calculated for AUPH; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 28.3%, ROIC 15.5%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Axsome Therapeutics, Inc. - Common Stock (AXSM)
- BridgeBio Pharma, Inc. - Common Stock (BBIO)
- Beam Therapeutics Inc. - Common Stock (BEAM)
- BioMarin Pharmaceutical Inc. - Common Stock (BMRN)
- Celldex Therapeutics, Inc. (CLDX)
- Corcept Therapeutics Incorporated - Common Stock (CORT)
- CRISPR Therapeutics AG - Common Shares (CRSP)
- Cytokinetics, Incorporated (CYTK)